RE: News4 Aug 2017 18:04
Tillerman, I'm more optimistic, but taking a long-term view.
Just been looking up Tom Nicolette on linkedin:-
President of Nicolette Consulting Group Limited
1982 – Present (35 years)
NCG has completed 15 management consulting engagements since 1999 with clients in France, Switzerland, Germany, United Kingdom, Mexico, Canada, Belgium and USA. The engagements have included turn-around management, formulating strategic initiatives, executing business plans, private placement fund raising, IPO listings on NASDAQ Capital Markets, Toronto Stock Exchange and the London Stock Exchange, creating liquidity events for clients and investors.
NCG is a privately held company incorporated in Delaware.
Interesting that he was CEO and President of Akers Biosciences, Inc. between April 2007 and March 2014, a company listed on NASDAQ and the LSE. AKR develops, manufactures and supplies rapid, point-of-care diagnostic testing products for hospital laboratories, government, military, law enforcement and doctors' offices thru its' six patented platform technologies and 11 core products. Most products are regulatory approved with 10 patents issued. So he does have that experience useful for DBC.
As JM infamously said in a twitter response to a question re LIFE's potential acquisition of DBC, 'watch this space'.
Hopefully, the fund-raising will be done in the next few months. What is unknown at this stage is in what form it will be, where (US or UK) and whether LIFE will be involved.